✦ LIBER ✦

A Phase II Trial of Piroxantrone in Advanced Ovarian Carcinoma after Failure of Platinum-Based Chemotherapy: Southwest Oncology Group Study 8904

✍ Scribed by Kathy S. Albain; P.Y. Liu; Alexander Hantel; Elizabeth A. Poplin; Robert V. O'Toole; James L. Wade III; Anne-Marie Maddox; David S. Alberts

Book ID: 115616559
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 277 KB
Volume: 57
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1995.1163

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Southwest Oncology Group Phase II Study

Southwest Oncology Group Phase II Study of Irinotecan in Patients with Advanced Transitional Cell Carcinoma of the Urothelium that Progressed After Platinum-Based Chemotherapy

✍ Tomasz M. Beer; Bryan Goldman; Craig R. Nichols; Daniel P. Petrylak; Manoj Agarw 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 107 KB

Phase II trial of trimetrexate in advanc

Phase II trial of trimetrexate in advanced esophageal cancer: A southwest oncology group study

✍ Thomas R. Fleming; Thomas D. Brown; S. William Ross; John S. Macdonald 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 202 KB

Phase II trial of topotecan in advanced

Phase II trial of topotecan in advanced gastric cancer: A Southwest Oncology Group study

✍ Jacqueline K. Benedetti; Howard A. Burris III; Stanley P. Balcerzak; John S. Mac 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 22 KB

Phase II trial of amonafide in previousl

Phase II trial of amonafide in previously treated patients with advanced ovarian cancer: A Southwest Oncology Group study

✍ Holly H. Gallion; P.Y. Liu; David E. Alberts; Robert V. O'Toole; Janet O'Sulliva 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 320 KB

Phase II evaluation of mitoxantrone in a

Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: A Southwest Oncology Group study

✍ Sarah A. Taylor; Thomas Fleming; Daniel D. Hoff; Joseph D. McCracken; Ronald M. 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 242 KB

Patient with advanced adenocarcinoma of the pancreas and no prior chemotherapy were treated on a Phase II trial of mitoxantrone. Doses were adjusted for hepatic dysfunction as defined by bilirubin. Twenty-four patients with a bilirubin less than or equal to 1.5 mg% received mitoxantrone 12 mg/m2 i.v

Phase II Trial of CI-958 in Recurrent Pl

Phase II Trial of CI-958 in Recurrent Platinum-Refractory Ovarian Carcinoma: A Gynecologic Oncology Group Study

✍ Mark A. Hoffman; John A. Blessing; Mark Morgan 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 34 KB